| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| David Arkowitz | Chief Financial Officer | $1,876,112 | 10 May 2021 | ||
| Adam Muzikant | Chief Business Officer | 19 Nov 2021 | |||
| Frederick W. Driscoll | Chief Financial Officer | 19 Nov 2021 | |||
| Samuel D. Colella | Director | 19 Nov 2021 | |||
| Heath Lukatch | Director | 19 Nov 2021 | |||
| Mark S. Levine | General Counsel | 19 Nov 2021 | |||
| Christina Willwerth | Chief Strategy Officer | 19 Nov 2021 | |||
| Melissa Layman | Chief Commercial Officer | 19 Nov 2021 | |||
| Patrick J. Mahaffy | Director | 19 Nov 2021 | |||
| Scott A. Canute | Director | 19 Nov 2021 | |||
| C. Ann Merrifield | Director | 19 Nov 2021 | |||
| Mark Stejbach | Director | 19 Nov 2021 | |||
| William T. Andrews | Chief Medical Officer | 19 Nov 2021 | |||
| Utpal Koppikar | Director | 19 Nov 2021 | |||
| Elizabeth Kwo | Director | 19 Nov 2021 | |||
| Alan Milinazzo | Director | 19 Nov 2021 | |||
| Kerry Wentworth | Chief Regulatory Officer | 19 Nov 2021 | |||
| Michael D. Clayman | President and CEO, Director | 19 Nov 2021 | |||
| Newtyn Management, LLC | 10%+ Owner | 19 Nov 2021 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||